Skip to main content
. Author manuscript; available in PMC: 2010 Oct 5.
Published in final edited form as: N Engl J Med. 2008 Nov 20;359(21):2233–2244. doi: 10.1056/NEJMoa0800971

Table 2.

Mortality Rates.

Variable Early
Antiretroviral
Therapy
(N = 252)
Deferred
Antiretroviral
Therapy
(N = 125)
Total
(N = 377)
Hazard Ratio
(95% CI)*
P Value
Deaths — no. (%) 10 (4) 20 (16) 30 (8) 0.24 (0.11–0.51) <0.001
Person-years of follow-up — no. 205 94 299
Overall death rate per 100 person-years — % (95% CI) 4.9 (2.3–9.0) 21.2 (13.0–32.7) 10.0 (6.8–14.3)
Rate of death during follow-up — % (95% CI)
 0–13 wk 9.8 (3.6–21.4) 40.6 (21.0–71.0)
 >13–26 wk 3.7 (0.4–13.2) 19.7 (6.4–45.9)
 >26–52 wk 3.1 (0.4–11.2) 6.8 (0.8–24.7)
*

Hazard ratios for death are for the comparison of the early-therapy groups with the deferred-treatment group.